ストックスクリーナーアプリを入手
1.03
8.04%
-0.09
アフターアワーズ：
1.01
-0.02
-1.94%
前日終値:
$1.12
開ける：
$1.09
24時間の取引高:
865.68K
Relative Volume:
1.42
時価総額：
$34.10M
収益：
-
当期純損益:
-
株価収益率:
-11.68
EPS:
-0.0882
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-26.95%
1か月 パフォーマンス:
-90.37%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$1.01
$1.12
1週間の範囲:
$1.01
$1.38
52週間の値動き範囲:
$1.01
$19.51
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
名前
Jupiter Neurosciences Inc
セクター
電話
(561) 406-6154
住所
1001 NORTH US HWY 1, JUPITER
JUNS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
1.03 | 34.10M | 0 | 0 | 0 | -0.0882 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Jupiter Neurosciences Inc (JUNS) 最新ニュース
Jupiter Neurosciences partners with Zina for Parkinson's trial - Investing.com India
Jupiter Neurosciences, Zina Biopharmaceuticals Collaborate on Phase 2a Parkinson's Disease Study - Marketscreener.com
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial - GlobeNewswire
Jupiter Neurosciences partners with Zina for Parkinson's trial By Investing.com - Investing.com South Africa
Wall Street Set to Open Slightly Lower Friday as Investors Await PMI, Housing Figures - TradingView
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
United States shares higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com India
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.93% - Investing.com UK
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Stock market news: Chanson International Holdings declined by 83.97% while Dogwood Therapeutics surged by 387.32% during mid day trading - Business Upturn
Stock market today: Icon Energy surged by 222.66% while Jupiter Neurosciences gained over 208.62% in early trading - Business Upturn
US Stocks Mixed; GE Aerospace Posts Upbeat Earnings - Benzinga
Modest Final Quarter Completes Shaky Biotech IPO Comeback For 2024 - News & Insights
Stock market news: Star Fashion Culture Holdings -78.42%, Lisata Therapeutics -33.08% among biggest losers in early trading - Business Upturn
Stock market today: Star Fashion Culture Holdings -79.05%, Lisata Therapeutics -23.34% among biggest losers in early trading - Business Upturn
Biopharma IPOs rebound slightly, as class of 2024 lags with a 29% average decline - BioWorld Online
Jupiter Neurosciences refocuses on NLRP3 inflammasome By Investing.com - Investing.com South Africa
Jupiter Neurosciences refocuses on NLRP3 inflammasome - Investing.com India
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials - GlobeNewswire
Jupiter Neurosciences announces focus on NLRP3 pathway in JOTROL trials - TipRanks
Jupiter Neurosciences Targets NLRP3 Inflammasome With JOTROL Platform for Alzheimer's Treatment - StockTitan
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
December's $4.69B in biopharma financings caps a $102.15B year - BioWorld Online
Jupiter Neurosciences Inc. (JUNS) reports earnings - Quartz
Jupiter Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Jupiter Neurosciences inks deal for Southeast Asia expansion By Investing.com - Investing.com Australia
Jupiter Neurosciences inks deal for Southeast Asia expansion - Investing.com
Jupiter Neurosciences adjusts CFO compensation - Investing.com
Greenridge sees upside in Jupiter Neurosciences stock By Investing.com - Investing.com Canada
Greenridge sees upside in Jupiter Neurosciences stock - Investing.com
Finance Watch: FOPO Surge Continues With Big Offerings From Revolution, NewAmsterdam - Citeline News & Insights
Tesla, Nvidia among Tuesday's market cap stock movers - Investing.com
Tesla, Nvidia among Tuesday's market cap stock movers By Investing.com - Investing.com UK
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday - Benzinga
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Marvell, Credo Tech lead Friday's market cap stock movers By Investing.com - Investing.com South Africa
Marvell, Credo Tech lead Friday's market cap stock movers - Investing.com India
Adobe, Ciena lead Thursday's market cap stock movers By Investing.com - Investing.com South Africa
Adobe, Ciena lead Thursday's market cap stock movers - Investing.com
Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On ThursdayAkso Health (NASDAQ:AHG), Bloom Energy (NYSE:BE) - Benzinga
After Making the IPO Jump, Biotechs Landed On a Slippery Slope - BioSpace
Opening Day: Jinxin Technology, zSpace make public debut - MSN
U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha
IPO NewsUS IPO Weekly Recap: ServiceTitan launches as small issuers slip through the IPO window - Renaissance Capital
Rx Rundown: Eli Lilly, Amgen, GSK and more - MM+M Online
Company behind novel Parkinson's disease treatment raises $11 million in IPO - The Business Journals
Jupiter IPOs to advance resveratrol-based treatments for neuroinflammation - Longevity.Technology
Jupiter Neurosciences Inc (JUNS) 財務データ
収益
当期純利益
現金流量
EPS
3.95%
2.39%
大文字化:
|
ボリューム (24 時間):